A hepatocyte-targeting nanoparticle for enhanced hepatobiliary magnetic resonance imaging
Huan Zhang,Yingkun Guo,Ju Jiao,Ying Qiu,Yuqing Miao,Yuan He,Zhenlin Li,Chunchao Xia,Li Li,Jing Cai,Ke Xu,Xiaoli Liu,Ce Zhang,Boon-Huat Bay,Shijie Song,Yanlian Yang,Mingli Peng,Yaoyu Wang,Haiming Fan
DOI: https://doi.org/10.1038/s41551-022-00975-2
IF: 28.1
2022-12-20
Nature Biomedical Engineering
Abstract:Hepatobiliary magnetic resonance imaging (MRI) can inform the diagnosis of liver tumours in patients with liver cirrhosis and hepatitis. However, its clinical utility has been hampered by the lack of sensitive and specific contrast agents, partly because hepatocyte-specific nanoparticles, regardless of their surface ligands, are readily sequestered by Kupffer cells. Here we show, in rabbits, pigs and macaques, that the performance of hepatobiliary MRI can be enhanced by an ultrasmall nanoparticle composed of a manganese ferrite core (3 nm in diameter) and poly(ethylene glycol)-ethoxy-benzyl surface ligands binding to hepatocyte-specific transmembrane metal and anion transporters. The nanoparticle facilitated faster, more sensitive and higher-resolution hepatobiliary MRI than the clinically used contrast agent gadoxetate disodium, a substantial enhancement in the detection rate (92% versus 48%) of early-stage liver tumours in rabbits, and a more accurate assessment of biliary obstruction in macaques. The nanoparticle's performance and biocompatibility support the further translational development of liver-specific MRI contrast agents.
engineering, biomedical